The Kama Flow team, consisting of Deputy Executive Director Elizaveta Rozhdestvenskaya and Investment Manager Sergey Gaivoronsky, took part in the Open Bio 2022 industry forum dedicated to the commercialization of ideas and business development in the field of life sciences.

The scientific communications platform worked in the Koltsovo Biotechnopark from September 27 to September 30. Within the framework of the event, a round table "The realities of the Russian investor: the Era of new opportunities" was held, at which Elizabeth and Sergey, as moderators, discussed with colleagues the current investment climate, as well as new opportunities for investors and measures to support portfolio projects.

In addition, Sergey Gaivoronsky moderated the expert session "Artificial Intelligence in Medicine", dedicated to discussing topical issues related to the introduction of AI technologies in healthcare and overcoming barriers to the development of companies operating in this segment.

More about the event: